VM

VHCP Management Portfolio holdings

AUM $93M
This Quarter Return
+24.06%
1 Year Return
-10.46%
3 Year Return
+232.85%
5 Year Return
10 Year Return
AUM
$434M
AUM Growth
+$434M
Cap. Flow
+$12.1M
Cap. Flow %
2.78%
Top 10 Hldgs %
86.36%
Holding
22
New
2
Increased
2
Reduced
Closed
3
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
JUNO
1
DELISTED
Juno Therapeutics, Inc.
JUNO
$97M 22.32% 1,749,999
ANAC
2
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$68.2M 15.7% 1,178,474
ADVM icon
3
Adverum Biotechnologies
ADVM
$64.6M
$56M 12.9% 1,382,735
GWPH
4
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$28.4M 6.54% 311,853
CHRS icon
5
Coherus Oncology, Inc. Common Stock
CHRS
$135M
$26M 5.99% 870,269
LRMR icon
6
Larimar Therapeutics
LRMR
$310M
$21.4M 4.94% 541,480
DYAX
7
DELISTED
DYAX CORPORATION
DYAX
$16.8M 3.86% 1,000,659
HRTX icon
8
Heron Therapeutics
HRTX
$207M
$15.9M 3.67% 1,095,734
BCRX icon
9
BioCryst Pharmaceuticals
BCRX
$1.74B
$15.8M 3.63% 1,744,356
ASND icon
10
Ascendis Pharma
ASND
$11.8B
$12.9M 2.97% +811,152 New +$12.9M
AVDL
11
Avadel Pharmaceuticals
AVDL
$1.43B
$8.99M 2.07% 500,000
ARCT icon
12
Arcturus Therapeutics
ARCT
$462M
$8.45M 1.94% +1,500,000 New +$8.45M
STML
13
DELISTED
Stemline Therapeutics, Inc.
STML
$6.53M 1.5% 451,400 +95,000 +27% +$1.37M
TXMD icon
14
TherapeuticsMD
TXMD
$12.8M
$5.12M 1.18% 846,500
LPCN icon
15
Lipocine
LPCN
$15.8M
$4.62M 1.06% 669,921
ZSPH
16
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$4.21M 0.97% 100,000
OCRX
17
DELISTED
Ocera Therapeutics, Inc.
OCRX
$3.32M 0.76% 703,730
VIRX
18
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
-536,189 Closed -$1.37M
NBSE
19
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
-477,000 Closed -$3.98M
RDUS
20
DELISTED
Radius Health, Inc.
RDUS
-233,294 Closed -$9.08M